Day: October 12, 2023

WellSky® Acquires Corridor, Expands Commitment to Offering Best-in-Class Coding, Revenue Cycle Management Services for Post-Acute Industry

The combined companies will work together to bolster providers’ ability to improve financial performance and succeed in value-based care arrangementsOVERLAND...

Parker Health and OutCare Health Forge Groundbreaking Research Partnership to Revolutionize LGBTQ+ Healthcare for Underserved Communities

LAS VEGAS--(BUSINESS WIRE)--#parkerhealth--Parker Health and OutCare Health proudly announce a groundbreaking research and care delivery partnership with a mission to...

120+ Provider Dermatology Practice Reports a 99% Net Collection Rate With eClinicalWorks Revenue Cycle Management (RCM)

The Dermatology Specialists experienced successful RCM Optimization Services with eClinicalWorksWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR, today announced that...

Imperative Care Announces Positive New Data Demonstrating the Use of Zoom Aspiration Catheters is Associated with Lower Procedural Cost in Patients with Acute Ischemic Stroke

Early Data Published in Interventional Neuroradiology Shows Angled TRX Tip Catheters Lead to Faster and Less Costly Stroke Thrombectomy ProceduresCAMPBELL,...

GE HealthCare Signs $44 Million Contract with BARDA to Develop Artificial Intelligence-Augmented Ultrasound Technology to Aid Clinicians in Diagnosing and Treating Traumatic Injury and Enhance National Preparedness for Mass Casualty Incidents

Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced the launch...

Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum

Top line results expected in the coming weeks for company's phase 3 OnTarget trial of crofelemer for preventative treatment of...

error: Content is protected !!